Evidence map›Paper›PMID 30933393›Full record

ArticleHead & neck2019

Organ preservation for patients with anterior mucosal squamous cell carcinoma of the nasal cavity: Rhinectomy-free survival in those refusing surgery.

Ximena Mimica, Yao Yu, Marlena McGill, Christopher A Barker, Sean McBride, Ian Ganly, Jennifer R Cracchiolo, Lara A Dunn, Nora Katabi, Kevin Sine and 4 more

Open access · greenAbstract read
In one paragraph

Article in Head & neck, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Ximena MimicaHead and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Yao YuDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Marlena McGillHead and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Christopher A BarkerDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Sean McBrideDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Ian GanlyHead and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Jennifer R CracchioloHead and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0003-4496-906X
Lara A DunnDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0001-5318-2571
Nora KatabiDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
Kevin SineProCure Proton Therapy Center, Somerset, New Jersey.
Dennis MahProCure Proton Therapy Center, Somerset, New Jersey.
Anna LeeDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Nancy LeeDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Marc A CohenHead and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0002-6104-7967
Memorial Sloan Kettering Cancer Center · USProCure (United States) · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Elisa de Stanchina · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

backgroundStandard treatment of squamous cell carcinoma (SCC) of the anterior nasal mucosa is surgical resection with or without postoperative radiation.

methodsRetrospective review of patients diagnosed with SCC of the nasal cavity between January 2000 and July 2018 who refused total rhinectomy and who were treated with radiation with or without chemotherapy with curative intent.

resultsEleven patients were identified, 73% had stage III or stage IV disease. Four patients were treated with intensity-modulated radiotherapy and seven with intensity-modulated proton radiotherapy. Concurrent chemoradiotherapy was used in nine patients (82%). With a median follow-up of 15 months (3-124 months), two patients experienced recurrence and one developed distant metastasis and died from disease. The 2-year rhinectomy-free survival rate was 88%. Two-year overall survival and recurrence-free survival were 100% and 75%, respectively.

conclusionA radiation-based approach for SCC of the nasal cavity mucosa is a valid option for selected patients who refuse up-front surgery.

Indexed as

Radiotherapy, Intensity-ModulatedAdultAgedAged, 80 and overAntineoplastic AgentsCarboplatinCarcinoma, Squamous CellChemoradiotherapyCisplatinFemaleHumansInduction ChemotherapyMaleMiddle AgedNasal CavityNoseAntineoplastic AgentsCarboplatinCisplatinPaclitaxelnasal cavityoutcomesradiotherapyrhinectomysquamous cell carcinoma

Identifiers

PMID30933393
PMCPMC6709873
OpenAlexW2926598339

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.